Sponsor Pipeline

Wang Xin Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07463248 PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular… Hepatocellular Carcinoma (HCC) Not Yet Recruiting
NCT07651007 Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for… Advanced Rectal Cancer Not Yet Recruiting
Phase 1/2
NCT07291947 PULSAR Combined With Immunotherapy and Chemotherapy Cholangiocarcinoma Recruiting
Disease Areas
Cholangiocarcinoma (1) Liver Cancer (1) Colorectal Cancer (1)
Get alerts when Wang Xin's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free